ImmuCell Corporation Construction Payable
ImmuCell Corporation (ICCC) had Construction Payable of $6.23 million as of 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Notes › Payables and Accruals › Accounts Payable and Accrued Liabilities › Accounts Payable
us-gaap:ConstructionPayableCurrentAndNoncurrent · last filed 2017-11-13
- 2017-09-30: Construction Payable $6.23M.
- 2017-06-30: Construction Payable $10.03M.
- 2017-03-31: Construction Payable $13.53M.
- 2016-12-31: Construction Payable $17.92M.
| Period end | Construction Payable |
|---|---|
| 2017-09-30 | $6.23M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $10.03M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $13.53M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $17.92M 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |